Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Formulation (FDF)
Dapagliflozin Tablets
Tablets · 5mg, 10mg
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB864)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Leuprorelin Acetate Microspheres for Injection（1 month）
Microspheres for Injection · 3.75mg/vial
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB863)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Paclitaxel For Injection (Albumin Bound)
For Injection · 100mg/vial
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB862)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Paliperidone Palmitate Injection (1 month)
Injection · 0.75ml:75mg; 1.0ml:100mg; 1.5ml:150mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB861)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Bupivacaine Liposome Injectable Suspension
Injectable · 133mg/10ml; 266mg/20ml
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB860)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Irinotecan Hydrochlorid Liposome injection
injection · 43mg/10ml
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB859)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Risperidone for Depot Suspension (2 weeks)
Suspension · 25mg; 37.5mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB858)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Doxorubicin Hydrochloride Liposome Injection
Injection · 20mg/10ml
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB857)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Meropenem for Injection and Sodium Chloride Injection
for Injection · 0.5g/100ml; 1.0g/100ml
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB856)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Cefuroxime Sodium for Injection and Sodium Chloride Injection
for Injection · 0.75g/100ml; 1.5g/100ml
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB855)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ceftriaxone Sodium for Injection and Sodium Chloride Injection
for Injection · 1.0g/100ml; 2.0g/100ml
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB854)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Bailing Capsules
Capsules · 0.5g/capsule
- Therapy
- Respiratory
- Status
- Official FDF licensing catalog (UB853)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China, Canada, Singapore
Formulation (FDF)
Orlistat Capsules
Capsules · 60mg; 120mg
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB852)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Voglibose Chewable Tablets / Capsules
Tablets · 0.2mg
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB851)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Olaparib Tablets
Tablets · 100mg; 150mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB850)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Canagliflozin Tablets
Tablets · 0.1g; 0.3g
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB849)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Pioglitazone Hydrochloride Tablets
Tablets · 15mg; 30mg
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB848)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Adefovir Dipivoxil Tablets
Tablets · 10mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB847)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Enoxacin Gluconate for Injection
for Injection · 0.1g; 0.2g
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB846)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ganciclovir for Injection
for Injection · 0.25g
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB845)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Clarithromycin for Suspension
Suspension · 0.125g; 0.25g
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB844)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tiopronin for Injection
for Injection · 0.1g
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB843)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Omeprazole and Sodium Bicarbonate Capsules
Capsules · Each capsule contains omeprazole 20mg and sodium bicarbonate 1100mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB842)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Pantoprazole Sodium Enteric-Coated Capsules
Capsules · 20mg; 40mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB841)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Pantoprazole Sodium For Injection
For Injection · 40mg; 60mg; 80mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB840)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tirofiban Hydrochloride for Injection
for Injection · 5mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB839)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Macitentan Tablets
Tablets · 10mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB838)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Oxaliplatin for Injection
for Injection · 50mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB837)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Adenosine Injection
Injection · 2ml：6mg; 30ml：90mg; 20ml：60mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB836)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Fondaparinux sodium injection
injection · 10mg/0.8ml； 7.5mg/0.6ml； 5mg/0.4ml； 2.5mg/0.5ml；
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB835)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Eltrombopag Olamine Tablet
Tablet · 12.5mg, 25mg, 50mg, 75mg
- Therapy
- Others > Hematology
- Status
- Official FDF licensing catalog (UB833)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Rimegepant Sulfate Orally Disintegrating Tablet
Tablet · 75mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB832)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Doxycycline Sustained-release Tablet
Tablet · 40mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB831)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Rivaroxaban Tablet
Tablet · 10mg, 15mg, 20mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB830)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, China, EU…
Formulation (FDF)
Ticagrelor Tablet
Tablet · 60mg, 90mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB829)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, China, EU
Formulation (FDF)
Captopril Tablet
Tablet · 12.5mg, 25mg, 50mg, 100mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB828)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, China
Formulation (FDF)
Doxycycline Hyclate Capsule/Tablet
Capsule · 100mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB827)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Pregabalin Capsule
Capsule · 25mg, 50mg, 75mg , 100mg, 150mg, 200mg, 225mg, 300mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB826)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, Taiwan, Philippines…
Formulation (FDF)
Rosuvastatin Calcium Tablet
Tablet · 5mg,10mg, 20mg, 40mg
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB825)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China, United States, EU…
Formulation (FDF)
Progesterone Injection
Injection · 1ml:50mg
- Therapy
- Others > Women's Health
- Status
- Official FDF licensing catalog (UB824)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Teriparatide
—
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB823)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Doxepin Hydrochloride Buccal Films
— · 2mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB821)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Perfluoropropane-Albumin Microspheres for Injection
Microspheres for Injection · 0.5g
- Therapy
- Others > Women's Health
- Status
- Official FDF licensing catalog (UB820)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Neostigmine Methylsulfate Injection
Injection · 2ml:1mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB819)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Magnesium Sulfate Injection
Injection · 10ml:5g
- Therapy
- Others > Women's Health
- Status
- Official FDF licensing catalog (UB818)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Clenicolin Phosphate for Injection
for Injection · 0.6g
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB817)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Flurbiprofen Patch
Patch · 20mg/40mg
- Therapy
- Others > Rheumatology
- Status
- Official FDF licensing catalog (UB816)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ketoprofen Patch
Patch · 20mg/40mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB815)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China